MIR3936: A Potential Drug Target and Biomarker (G100500865)
MIR3936: A Potential Drug Target and Biomarker
MIR3936 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a potential drug target and biomarker that has been identified for its role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The discovery of MIR3936 as a potential drug target and biomarker comes from a study conducted by a team of researchers at the University of California, San Diego. The researchers used a variety of techniques, including mass spectrometry and biochemical assays, to identify MIR3936 as a protein that is expressed in the brain and is involved in several important cellular processes, including cell signaling, inflammation, and stress responses.
MIR3936 has also been shown to play a role in several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These studies suggest that MIR3936 may be a useful target for new therapies that can treat these conditions.
In addition to its potential use as a drug target, MIR3936 has also been identified as a potential biomarker for several diseases. For example, the researchers found that MIR3936 is expressed in the brains of individuals with Alzheimer's disease, and that levels of MIR3936 are decreased in the brains of individuals with Parkinson's disease. These findings suggest that MIR3936 may be a useful biomarker for these conditions.
The identification of MIR3936 as a potential drug target and biomarker also has implications for the development of new therapies for these conditions. By targeting MIR3936 with small molecules or other compounds, researchers may be able to treat these diseases and improve the quality of life for those affected.
Overall, the discovery of MIR3936 as a potential drug target and biomarker is a promising development in the field of neuroscience. Further research is needed to fully understand its role in these diseases and to develop new treatments.
Protein Name: MicroRNA 3936
The "MIR3936 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3936 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR3936HG | MIR3937 | MIR3938 | MIR3939 | MIR3940 | MIR3941 | MIR3942 | MIR3943 | MIR3944 | MIR3945 | MIR3945HG | MIR3960 | MIR3972 | MIR3973 | MIR3974 | MIR3976 | MIR3976HG | MIR3977 | MIR3978 | MIR409 | MIR410 | MIR411 | MIR412 | MIR421 | MIR422A | MIR423 | MIR424 | MIR425 | MIR4251 | MIR4252 | MIR4253 | MIR4254 | MIR4255 | MIR4256 | MIR4257 | MIR4258 | MIR4259 | MIR4260 | MIR4261 | MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317
